Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dr Reddys Laboratories (RDY) Total Current Liabilities (2016 - 2025)

Historic Total Current Liabilities for Dr Reddys Laboratories (RDY) over the last 14 years, with Q3 2025 value amounting to $1.7 billion.

  • Dr Reddys Laboratories' Total Current Liabilities rose 1205.92% to $1.7 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $1.7 billion, marking a year-over-year increase of 1205.92%. This contributed to the annual value of $1.5 billion for FY2025, which is 3255.21% up from last year.
  • Per Dr Reddys Laboratories' latest filing, its Total Current Liabilities stood at $1.7 billion for Q3 2025, which was up 1205.92% from $1.5 billion recorded in Q1 2025.
  • Dr Reddys Laboratories' 5-year Total Current Liabilities high stood at $1.7 billion for Q3 2025, and its period low was $1.0 billion during Q3 2022.
  • For the 5-year period, Dr Reddys Laboratories' Total Current Liabilities averaged around $1.3 billion, with its median value being $1.2 billion (2021).
  • As far as peak fluctuations go, Dr Reddys Laboratories' Total Current Liabilities tumbled by 1647.75% in 2023, and later soared by 5159.2% in 2024.
  • Dr Reddys Laboratories' Total Current Liabilities (Quarter) stood at $1.2 billion in 2021, then fell by 13.42% to $1.0 billion in 2022, then increased by 1.45% to $1.0 billion in 2023, then soared by 51.59% to $1.5 billion in 2024, then grew by 12.06% to $1.7 billion in 2025.
  • Its Total Current Liabilities stands at $1.7 billion for Q3 2025, versus $1.5 billion for Q1 2025 and $1.5 billion for Q3 2024.